IMPORTANCE Magnetic resonance (MR) enterography has the advantage over other techniques of being noninvasive, lacking ionizing radiation, and demonstrating excellent soft-tissue contrast to evaluate pediatric patients with inflammatory bowel disease (IBD).
I nflammatory bowel disease (IBD) is relatively common in pediatric populations and its incidence in children has increased. 1 Although histopathologic evaluation via tissue biopsy through ileocolonoscopy is the primary tool for the diagnosis of IBD, assessments with small-bowel imaging are frequently performed in almost all patients. Modalities for bowel imaging include a small-bowel follow-through, abdominal ultrasonography (US), computed tomographic (CT) enterography, and capsule endoscopy. However, the small-bowel followthrough has low sensitivity for detection of the involved bowel segment, and significant exposure to ionizing radiation is the major drawback of this study. 2 Abdominal US is a noninvasive and radiation-free imaging modality; however, it does not allow for whole-bowel imaging and depends on the operator's experience. In addition, a recent study reported that abdominal US had moderate interrater agreement and low agreement with MR enterography, especially in mid-and proximal smallbowel imaging. 3 Computed tomographic enterography can objectively demonstrate mural as well as extraintestinal diseases; however, careful consideration should be given when performing CT enterography owing to radiation exposure. Capsule endoscopy can directly visualize the small bowel, but evaluation of extraintestinal disease is impossible and capsule retention, which necessitates surgical exploration, may occur in patients who have substantial luminal narrowing. Magnetic resonance (MR) enterography has rapidly emerged as the diagnostic imaging modality of choice to identify disease involvement and assess disease activity.
4-21 Magnetic resonance enterography has the advantage of being noninvasive, lacking ionizing radiation, and demonstrating excellent soft-tissue contrast. Because children are more sensitive to ionizing radiation and they have to undergo multiple imaging studies during their lifetime to monitor disease activity, MR enterography is the best radiologic imaging modality in the field of pediatric IBD. 22 As interest in MR enterography grows, there are multiple studies that evaluated the diagnostic performance of MR enterography in pediatric patients. However, to our knowledge, the diagnostic performance of MR enterography in that population has not been systematically evaluated. Moreover, factors affecting the diagnostic performance should be identified if heterogeneity exists. Therefore, the purpose of our study was to evaluate the diagnostic performance of MR enterography for detection of active inflammation using histopathology as the reference standard in children and adolescents with known or suspected IBD.
Methods
This systematic review and meta-analysis was performed and is reported in accordance with the PRISMA guidelines. 23 This study was approved by Asan Medical Center. 
Literature Search

Inclusion Criteria
Studies or subsets of studies were included if they satisfied all of the following criteria: (1) involved pediatric patients who underwent MR enterography for known or suspected IBD, (2) included reference standards based on histopathologic test findings, and (3) contained results published in sufficient detail for reconstruction of 2 × 2 tables for determination of the diagnostic performance of MR enterography for detection of active inflammation.
Exclusion Criteria
Studies were excluded if any of following criteria were met: (1) case reports or case series involving fewer than 10 patients; (2) conference abstracts, letters, editorials, reviews, meta-analyses, consensus statements, and guidelines; (3) studies focusing on topics other than the use of MR enterography to diagnose active inflammation; (4) studies with partially overlapping patient populations; and (5) studies using clinical setting or other imaging modalities as a reference standard. Two of us (H.M.Y., with 4 years of experience in pediatric radiology, and C.H.S., with 4 years of experience performing systematic reviews and meta-analyses) independently assessed the eligibility of the articles selected from the literature.
Data Extraction and Quality Assessment
We extracted the following data on study design and results from the included studies using a standardized form: (1) study characteristics (authors, year of publication, affiliation, country of origin, duration of patient recruitment, and study design), (2) demographic and clinical characteristics (sample size, male to female ratio, patient age, and study population), (3) technical characteristics of MR enterography (scanner manufacturer and model, magnetic field strength, bowel preparation, spasmolytic agents, and specific sequences used), (4) MR enterography interpretation (number of reviewers, experience, and blinding to clinicopathologic findings), (5) time intervals between MR enterography and the reference standard, and (6) diagnostic performance of MR enterography (type of analysis and bowel location). The methodologic quality of the studies was evaluated using tailored questionnaires and criteria by Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2). 24 Data extraction and quality assessment were performed independently by 2 of us (H.M.Y. and C.H.S.).
Data Synthesis and Analysis
The diagnostic performance of MR enterography for detection of active inflammation in pediatric patients with known or suspected IBD was the primary outcome for our metaanalysis. Heterogeneity was determined using the inconsistency index (I 2 ) as follows: 0% to 40%, might not be important; 30% to 60%, moderate heterogeneity; 50% to 90%, substantial heterogeneity; and 75% to 100%, considerable heterogeneity. 25 The threshold effect was analyzed by visual assessment of the coupled forest plots of sensitivity and specificity. The Spearman correlation coefficient between the sensitivity and false-positive rates greater than 0.6 was assessed to indicate a considerable threshold effect. 26 The pooled sensitivity and specificity and their 95% CIs were calculated using the bivariate random-effects model. [27] [28] [29] [30] [31] For graphic presentation of the study results, a hierarchical summary receiver operating characteristic (HSROC) curve with a 95% confidence region and prediction region was plotted. Publication bias was assessed using the Deeks funnel plot, and statistical significance was determined with the Deeks asymmetry test. 32 We performed subgroup analyses to assess various clinical settings: (1) per-patient analysis, (2) per-lesion analysis, and (3) assessment of overall bowel segments for all studies. We also performed meta-regression to explain the effects of heterogeneity. The following covariates were considered for the bivariate model: (1) study design (prospective vs retrospective), (2) population (Crohn disease vs IBD), (3) scanner manufacturer (GE vs Philips, GE vs Siemens, and Siemens vs Philips), (4) magnetic field strength of MR (3.0 vs 1.5 T), (5) use of spasmolytic agents, (6) use of diffusion-weighted imaging (DWI), (7) MR enterography reviewers blinded to pathologic test findings, (8) time intervals between MR enterography and the reference standard (≤1 month vs >1 month), and (9) bowel location (overall vs small bowel). P values <.05 were considered as having statistical significance. The metandi and midas modules in Stata, version 10.0 (StataCorp LP) and R, version 3.2.3 (R Foundation) with the mada module were used for statistical analyses.
Results
Literature Search
Our detailed study selection process is described in Figure 1 . The systematic literature search initially identified 550 articles. After removing 175 duplicates, screening of the 375 titles and abstracts was performed and a total of 328 articles were excluded. Searches of the bibliographies of articles identified 1 additional eligible study. 8 Full-text reviews of 48 potentially eligible articles were performed and 30 articles were excluded for the following reasons: 14 articles with insufficient data to reconstruct 2 × 2 tables, 10 articles that were not in the field of interest, 3 articles that included partially overlapping patient cohorts with other studies, [33] [34] [35] and 3 articles that used clinical settings or imaging modalities other than histopathological findings as a reference standard. [36] [37] [38] Finally, 18 original articles including a total of 687 patients evaluating the diagnostic performance of MR enterography for detection of active inflammation in patients with known or suspected IBD were included in our study.
4-21
Characteristics of the Included Studies
The detailed patient characteristics are reported in Table 1 . Nine of the included studies were prospective, 6,9,11-13,17,18,20,21 and the remaining 9 studies were retrospective. 4, 5, 7, 8, 10, [14] [15] [16] 19 The size of the study population ranged from 15 to 91 patients and the patients had a mean age of 9.9-17.7 years. In 10 studies, the population comprised patients with known or suspected Crohn disease, 4-7,11,13,16-20 and in 8 studies, the study population comprised patients with known or suspected IBD.
8-10,12,14,15,17,21
Further detailed characteristics of the studies are summarized in Table 2 . Magnetic resonance enterography was performed using 1.5-T scanners in 12 studies, 5,7,9-11,13-15,17-20 3.0-T scanners in 2 studies, 12,21 and either 1.5-or 3.0-T scanners in 2 studies. ; and psyllium husk, 1 study. 21 In addition, 11 studies used spasmolytic agents. [5] [6] [7] 11, 12, 14, 15, 17, [19] [20] [21] In almost all studies, the MR enterography protocol included dynamic contrast-enhanced images. In 7 studies, MR enterography protocol included DWI.
4,7-10,12,19
One study included the protocol with DWI and T2 fusion images, 8 and 1 study included a CAIPIRINHA (controlled aliasing in parallel imaging results in higher acceleration) sequence.
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Magnetic resonance enterography was interpreted by 1 to 3 radiologists, and the level of experience of the readers ranged from 2 to 20 years in the pediatric radiology field. In most studies, the readers were blinded to patients' clinicopathologic findings 4,5,7-11,13-18,20,21
; however, 3 studies were not explicit in terms of blinding. 6, 12, 19 In the majority of the studies, time intervals between MR enterography and the reference standard were less than 1 month; however, the details were not reported in 4 studies. 1 study based on the colon, 10 and 1 study based on the terminal ileum. 16 The quality of the included studies using QUADAS-2 was moderate overall, and all of the studies satisfied 4 or more of the 7 items (eFigure 1 in the Supplement). 
Diagnostic Performance of MR Enterography
The sensitivity and specificity of the individual studies were 53% to 100% and 50% to 100%, respectively. The Q test demonstrated that heterogeneity was present (P < .00). The Higgins I 2 statistic demonstrated substantial heterogeneity in terms of sensitivity (I 2 = 84.1%) and specificity (I 2 = 68.8%).
The coupled forest plot of sensitivity and specificity revealed the lack of a threshold effect ( Figure 2) . The Spearman correlation coefficient between the sensitivity and false-positive rate was 0.127 (95% CI, −0.361 to 0.560), also indicating the no-threshold effect. For all 18 studies, the summary sensitivity was 83% (95% CI, 75%-89%) and the summary specificity was 93% (95% CI, 90%-95%) (Figure 2 ). There was a small difference between the 95% confidence region and the 95% prediction region, indicating a low possibility of heterogeneity between the studies in the HSROC curve (eFigure 2 in the Supplement). The area under the HSROC curve was 0.95 (95% CI, 0.93-0.97). In the Deeks funnel plot, the likelihood of publication bias was low (P = .13 for slope coefficient) (eFigure 3 in the Supplement).
Subgroup Analysis
We performed multiple subgroup analyses to assess various clinical settings. In per-patient analysis (n = 13), the summary sensitivity was 86% (95% CI, 78%-91%; I 2 = 54.9%) and specificity was 91% (95% CI, 82%-96%; I 2 = 56.9%). In perlesion analysis (n = 7), the summary sensitivity was 72% (95% CI, 55%-84%; I 2 = 91.9%) and the summary specificity was 93%
(95% CI, 90%-95%; I 2 = 62.9%). In terms of overall bowel segments (n = 13), a summary sensitivity was 83% (95% CI, 73%-90%; I 2 = 88.8%) with a specificity of 93% (95% CI, 90%-95%; I 2 = 73.4%).
Meta-Regression
To explain the effects of heterogeneity, meta-regression was performed ( Table 3) . Among the various potential covariates, study design, population, scanner manufacturer, magnetic field strength, use of spasmolytic agents, use of DWI, MR enterography reviewers blinded to pathologic findings, and time intervals between MR enterography and the reference standard were associated with study heterogeneity. However, among these variables, only scanner manufacturer (73% in studies using GE Healthcare vs 93% in studies using Siemens Corp) showed a clinically meaningful difference in sensitivity. Other variables did not show clinically meaningful differences, although there were statistically significant differences.
Discussion
Our meta-analysis confirms that the diagnostic performance of MR enterography in determination of active inflammation in pediatric patients with IBD was within the clinically acceptable range, depicting a summary sensitivity of 83% (95% CI, 75%-89%), summary specificity of 93% (95% CI, 90%-95%), and area under the HSROC curve of 0.95 (95% CI, 0.93-0.97). In perpatient analysis, the summary sensitivity was 86% (95% CI, 78%-91%) and specificity was 91% (95% CI, 82%-96%). In per-lesion analysis, the summary sensitivity was only 72% (95% CI, 55%-84%) and specificity was 93% (95% CI, 90%-95%). There was substantial heterogeneity across the studies and scanner manufacturer was a statistically significant and clinically meaningful cause of heterogeneity in meta-regression analysis. Based on our results, MR enterography, which is a noninvasive and radiation-free modality, demonstrates high diagnostic performance in the diagnosis of active inflammation in pediatric patients with IBD, especially at the per-patient level.
Imaging studies for the diagnosis and monitoring of pediatric patients with IBD should be noninvasive and highly accurate. Being radiation-free is more important because the patients undergo multiple imaging studies in their lifetime. Its noninvasive technique and lack of radiation are undoubtedly benefits of MR enterography. In terms of the diagnostic accuracy of MR enterography, our study provides solid evidence for the high diagnostic performance of this modality. The summary sensitivity and specificity that we noted were 83% (95% CI, 75%-89%) and 93% (95% CI, 90%-95%), respectively. Previous studies regarding the diagnostic performance of MR enterography in adults with Crohn disease demonstrated a summary sensitivity of 80% to 88% and a summary specificity of 81% to 90%, [39] [40] [41] which were comparable to those of our study.
There was substantial heterogeneity in terms of the sensitivity (I 2 = 84.1%) and specificity (I 2 = 68.8%). In the subgroup per-patient analysis, study heterogeneity was reduced in both sensitivity (I 2 = 54.9%) and specificity (I 2 = 56.9%). Regarding the meta-regression analysis for investigating the causes of the heterogeneity, scanner manufacturer was a clinically meaningful factor affecting study heterogeneity in our study. However, 7 studies used Siemens Corp products only, 5,7,10,11,13,18,20 3 studies used GE Healthcare products, 8, 14, 15 3 studies used Philips, 12,19,21 and 2 studies used Siemens Corp or GE Healthcare equipment. 4, 9 Owing to the paucity of the studies, caution is needed when interpreting this result. Pulse sequences in pediatric MR enterography presently are recommended to include T2-weighted images, DWI, and dynamic precontrast and postcontrast T1-weighted images. 42 Recently, the use of DWI has been expanded to evaluations of the bowel inflammation in Crohn disease and the technique has become more popular in imaging of IBD. 43 Restricted diffusion (ie, high signal intensity on DWI with low apparent diffusion coefficients) within the bowel wall is known to reflect active inflammation. 42, 44 In our meta-regression analysis, the use of DWI was associated with study heterogeneity in terms of sensitivity (with DWI, 83%; 95% CI, 72%-95% vs without DWI, 87%; 95% CI, 81%-94%). This minute difference in sensitivity between 2 groups might not be clinically significant. Moreover, only 1 study provided head-to-head comparison between conventional MR enterography with DWI and without DWI. 4 There were limited studies that compared conventional MR enterography and DWI in pediatric patients; thus, further studies with head-to-head comparison are needed.
In terms of the use of spasmolytic agents, a statistically significant difference was observed in specificity in metaregression analysis, but this finding was clinically insignificant (92% in studies with vs 93% in studies without spasmolytic agents) Although several studies reported that MR enterogra- phy might be performed without spasmolytic agents, 45, 46 those agents are generally administered in clinical practice and recommended for use. 47 A recent study revealed that omitting spasmolytic agents might cause significant loss in the sensitivity of DWI in evaluating bowel inflammation in adults with Crohn disease. 48 In this regard, comparison between diagnostic benefits vs any adverse effects as well as costeffectiveness for the use of spasmolytic agents is needed for further investigation in pediatric patients. We performed multiple subgroup analyses. When we restricted subgroup analysis to the per-patient level using 13 studies, the range of diagnostic performance was within clinically acceptable levels with respect to sensitivity (86%; 95% CI, 78%-91%; I 2 = 54.9%) and specificity (91%; 95% CI, 82%-96%; I 2 = 56.9%). In contrast, per-lesion analysis using 7 studies showed lower summary sensitivity (72%; 95% CI, 55%-84%; I 2 = 91.9%) but similar summary specificity (93%; 95% CI, 90%-95%; I 2 = 62.9%), compared with per-patient analysis. Regarding the lower sensitivity in per-lesion analysis, endoscopy is unable to assess proximal small-bowel diseases, and the terminal ileum cannot always be intubated. 5 These drawbacks of endoscopic evaluation, which was a standard of our analysis, may result in lower sensitivity in per-lesion analysis. Moreover, lower detection rates may be attributable to bowel loops with inadequate fluid distention, particularly in the colorectum and jejunum.
Limitations
There were some limitations in our study. First, the heterogeneity was substantial. To overcome this heterogeneity, we performed meta-regression and multiple subgroup analyses. We found several factors associated with the heterogeneity; however, some factors remain unexplained. However, we applied solid and robust methodology for the systematic review and meta-analysis using the guidelines published by the Cochrane Collaboration. 49 Second, 9 of 18 studies were retrospective, resulting in a high risk of bias in patient selection.
Conclusions
Magnetic resonance enterography, which is a noninvasive and radiation-free modality, demonstrates high diagnostic performance in the diagnosis of active inflammation in pediatric patients with known or suspected IBD, especially at the perpatient level. We hope that our study might be evidence of justification for the application of MR enterography in this population. 
